COVID-19: The immune responses and clinical therapy candidates

S Zhand, M Saghaeian Jazi, S Mohammadi… - International journal of …, 2020 - mdpi.com
The pandemic of coronavirus disease 2019 (COVID-19), with rising numbers of patients
worldwide, presents an urgent need for effective treatments. To date, there are no therapies …

COVID-19: Diagnostics, therapeutic advances, and vaccine development

S Majid, MS Khan, S Rashid, A Niyaz, R Farooq… - Current Clinical …, 2021 - Springer
Abstract Purpose of Review Human race is currently facing the wrath of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly transmittable and pathogenic …

A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for …

CR Triggle, D Bansal, H Ding, MM Islam… - Frontiers in …, 2021 - frontiersin.org
COVID-19 emerged from China in December 2019 and during 2020 spread to every
continent including Antarctica. The coronavirus, SARS-CoV-2, has been identified as the …

Approaches towards fighting the COVID‑19 pandemic

SC Tsai, CC Lu, DT Bau, YJ Chiu… - International …, 2021 - spandidos-publications.com
Abstract The coronavirus disease 2019 (COVID‑19) outbreak, which has caused> 46
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …

COVID-19 therapeutic options under investigation

M Kaddoura, M AlIbrahim, G Hijazi… - Frontiers in …, 2020 - frontiersin.org
Since its emergence in China in December 2019, COVID-19 has quickly spread around the
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …

[HTML][HTML] Pathophysiology and potential therapeutic candidates for COVID-19: a poorly understood arena

A Samaddar, M Grover, VL Nag - Frontiers in pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), an acute onset pneumonia caused by a novel
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …

Beyond vaccines: clinical status of prospective COVID-19 therapeutics

S Kumar, DM Çalışkan, J Janowski, A Faist… - Frontiers in …, 2021 - frontiersin.org
Since November 2019 the SARS-CoV-2 pandemic has caused nearly 200 million infection
and more than 4 million deaths globally (Updated information from the World Health …

[HTML][HTML] An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics

D Wang, Z Li, Y Liu - Journal of infection and public health, 2020 - Elsevier
Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …

Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics

N Ebrahimi, S Aslani, F Babaie… - International …, 2020 - Elsevier
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) is responsible for recent
ongoing public health emergency in the world. Sharing structural and behavioral similarities …

The trinity of COVID-19: immunity, inflammation and intervention

MZ Tay, CM Poh, L Rénia, PA MacAry… - Nature Reviews …, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into …